Notably, PRL is higher in patients with MS or NMO during attacks compared with phases of remission [153] but it is still unclear whether hyperprolactinaemia is a primary cause or a secondary effect of the disease. This evidence concerns the gene PRL and Increased circulating prolactin concentration.